Use of estimated glomerular filtration rate for drug dosing in the chronic kidney disease patient

Joanna Laizure, Heather A. Nyman

Research output: Contribution to journalReview article

30 Citations (Scopus)

Abstract

Purpose of Review: Assessment of kidney function is necessary to stage chronic kidney disease (CKD) and appropriately dose medications. The Cockcroft-Gault equation provides an estimate of creatinine clearance (eClCr) and is the method commonly referenced in pharmacokinetic studies. The Modification of Diet in Renal Disease (MDRD) and CKD-Epidemiology Collaboration (EPI) equations provide an estimate of glomerular filtration rate (eGFR), with the MDRD eGFR now automatically reported by most clinical laboratories. This review describes the differences in the Cockcroft-Gault, MDRD, and CKD-EPI equations and considerations when applying estimates from these equations for drug dosing. Recent Findings: Studies evaluating drug-dosing regimens using eClCr and eGFR differ in their results depending on the population in which the equation is applied, the adjustment factors used to account for body size, and the number of dosing levels for a particular medication. The largest study to evaluate drug regimen design by method concluded that either the eGFR or Cockcroft-Gault estimates could be used for drug dosing. Differences in methodology among studies are a key factor in evaluating these results and will be highlighted in this review. Summary: The Cockcroft-Gault, MDRD, and CKD-EPI equations provide reasonable estimates of kidney function; however, clinicians must understand the limitations when using these estimates for drug regimen design.

Original languageEnglish (US)
Pages (from-to)482-491
Number of pages10
JournalCurrent opinion in nephrology and hypertension
Volume20
Issue number5
DOIs
StatePublished - Sep 1 2011

Fingerprint

Glomerular Filtration Rate
Chronic Renal Insufficiency
Diet Therapy
Kidney
Pharmaceutical Preparations
Epidemiology
Drug Design
Body Size
Creatinine
Pharmacokinetics
Population

All Science Journal Classification (ASJC) codes

  • Nephrology
  • Internal Medicine

Cite this

Use of estimated glomerular filtration rate for drug dosing in the chronic kidney disease patient. / Laizure, Joanna; Nyman, Heather A.

In: Current opinion in nephrology and hypertension, Vol. 20, No. 5, 01.09.2011, p. 482-491.

Research output: Contribution to journalReview article

@article{c947ceec95c74c148280ba0febc6327e,
title = "Use of estimated glomerular filtration rate for drug dosing in the chronic kidney disease patient",
abstract = "Purpose of Review: Assessment of kidney function is necessary to stage chronic kidney disease (CKD) and appropriately dose medications. The Cockcroft-Gault equation provides an estimate of creatinine clearance (eClCr) and is the method commonly referenced in pharmacokinetic studies. The Modification of Diet in Renal Disease (MDRD) and CKD-Epidemiology Collaboration (EPI) equations provide an estimate of glomerular filtration rate (eGFR), with the MDRD eGFR now automatically reported by most clinical laboratories. This review describes the differences in the Cockcroft-Gault, MDRD, and CKD-EPI equations and considerations when applying estimates from these equations for drug dosing. Recent Findings: Studies evaluating drug-dosing regimens using eClCr and eGFR differ in their results depending on the population in which the equation is applied, the adjustment factors used to account for body size, and the number of dosing levels for a particular medication. The largest study to evaluate drug regimen design by method concluded that either the eGFR or Cockcroft-Gault estimates could be used for drug dosing. Differences in methodology among studies are a key factor in evaluating these results and will be highlighted in this review. Summary: The Cockcroft-Gault, MDRD, and CKD-EPI equations provide reasonable estimates of kidney function; however, clinicians must understand the limitations when using these estimates for drug regimen design.",
author = "Joanna Laizure and Nyman, {Heather A.}",
year = "2011",
month = "9",
day = "1",
doi = "10.1097/MNH.0b013e328348c11f",
language = "English (US)",
volume = "20",
pages = "482--491",
journal = "Current Opinion in Nephrology and Hypertension",
issn = "1062-4821",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Use of estimated glomerular filtration rate for drug dosing in the chronic kidney disease patient

AU - Laizure, Joanna

AU - Nyman, Heather A.

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Purpose of Review: Assessment of kidney function is necessary to stage chronic kidney disease (CKD) and appropriately dose medications. The Cockcroft-Gault equation provides an estimate of creatinine clearance (eClCr) and is the method commonly referenced in pharmacokinetic studies. The Modification of Diet in Renal Disease (MDRD) and CKD-Epidemiology Collaboration (EPI) equations provide an estimate of glomerular filtration rate (eGFR), with the MDRD eGFR now automatically reported by most clinical laboratories. This review describes the differences in the Cockcroft-Gault, MDRD, and CKD-EPI equations and considerations when applying estimates from these equations for drug dosing. Recent Findings: Studies evaluating drug-dosing regimens using eClCr and eGFR differ in their results depending on the population in which the equation is applied, the adjustment factors used to account for body size, and the number of dosing levels for a particular medication. The largest study to evaluate drug regimen design by method concluded that either the eGFR or Cockcroft-Gault estimates could be used for drug dosing. Differences in methodology among studies are a key factor in evaluating these results and will be highlighted in this review. Summary: The Cockcroft-Gault, MDRD, and CKD-EPI equations provide reasonable estimates of kidney function; however, clinicians must understand the limitations when using these estimates for drug regimen design.

AB - Purpose of Review: Assessment of kidney function is necessary to stage chronic kidney disease (CKD) and appropriately dose medications. The Cockcroft-Gault equation provides an estimate of creatinine clearance (eClCr) and is the method commonly referenced in pharmacokinetic studies. The Modification of Diet in Renal Disease (MDRD) and CKD-Epidemiology Collaboration (EPI) equations provide an estimate of glomerular filtration rate (eGFR), with the MDRD eGFR now automatically reported by most clinical laboratories. This review describes the differences in the Cockcroft-Gault, MDRD, and CKD-EPI equations and considerations when applying estimates from these equations for drug dosing. Recent Findings: Studies evaluating drug-dosing regimens using eClCr and eGFR differ in their results depending on the population in which the equation is applied, the adjustment factors used to account for body size, and the number of dosing levels for a particular medication. The largest study to evaluate drug regimen design by method concluded that either the eGFR or Cockcroft-Gault estimates could be used for drug dosing. Differences in methodology among studies are a key factor in evaluating these results and will be highlighted in this review. Summary: The Cockcroft-Gault, MDRD, and CKD-EPI equations provide reasonable estimates of kidney function; however, clinicians must understand the limitations when using these estimates for drug regimen design.

UR - http://www.scopus.com/inward/record.url?scp=80051786576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051786576&partnerID=8YFLogxK

U2 - 10.1097/MNH.0b013e328348c11f

DO - 10.1097/MNH.0b013e328348c11f

M3 - Review article

VL - 20

SP - 482

EP - 491

JO - Current Opinion in Nephrology and Hypertension

JF - Current Opinion in Nephrology and Hypertension

SN - 1062-4821

IS - 5

ER -